Word: mathering
(lookup in dictionary)
(lookup stats)
Dates: all
Sort By: most recent first
(reverse)
...Jennie Mather left biotech company Genentech also out of frustration when, she says, her bosses wouldn't accept her approach to fighting cancer. She argued that what really counts in a target protein--that is, a protein that causes a disease and that a drug would aim to disable--is the protein's surface. Because a body's natural antibodies do their work entirely on the cell's exterior, she reasoned, drugs should work the same way. Such thinking was heresy to Genentech, whose scientists, she says, generally analyze a target's entire genetic structure. "They were just interested...
Genentech says it pioneered the use of antibodies that target the surface protein of cancer, and its popular drugs work on that principle. Nevertheless, Mather saw a way to carve several years out of drug development and left to found Raven Biotechnologies, a drug-discovery company based in South San Francisco. She created a process to keep cells alive outside the body, so she could test her theory in the lab. Her efforts paid off. In December the U.S. Food and Drug Administration approved one of her drugs for human testing. The drug, called RAV 12, is a protein that...
...time of the Mather Lather, neither McLoughlin nor Kidd worked in University Hall. The two were appointed in the fall...
...problem with Mather Lather had more to do with over-capacity, rowdiness and the out-of-control nature of it all,” Cambridge Licensing Commissioner Richard Scali said in a May 2003 interview with The Crimson...
...don’t think ‘innate abilities’ should be our go-to hypothesis when it’s the weakest one we have now,” said Jessica L. Jones ’06, a biological anthropology concentrator in Mather House...